If maximum weight loss is your priority and youre willing to use the highest available dose, both medications can now achieve comparable results
Less physical activity Maintaining or increasing exercise is important for ongoing weight management
GLP-1 medications are FDA-approved for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27-29.9) with at least one weight-related comorbidity
We ensure high energy density and tight cell matching for consistent, repeatable performance
The Journal of clinical investigation, 131(1), e140065
Min SH, Yoon JH, Moon SJ, Hahn S, Cho YM (2018) Combination of sodium-glucose cotransporter 2 inhibitor and dipeptidyl peptidase-4 inhibitor in type 2 diabetes: a systematic review with meta-analysis